Vimarsana
Biggest News Aggregation in the World

Page 11 - Breakthrough Device News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Breakthrough Device. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Breakthrough Device Today - Breaking & Trending Today

New Hope In Cancer Battle: FDA Grants Breakthrough Device Status To Vivos Inc.'s RadioGel - Vivos (OTC:RDGL) - Vimarsana News

New Hope In Cancer Battle: FDA Grants Breakthrough Device Status To Vivos Inc.'s RadioGel - Vivos (OTC:RDGL)

In a significant advancement for cancer therapy, the Food and Drug Administration (FDA) has awarded RadioGel Precision Radionuclide Therapy the coveted Breakthrough Device Designation.

New Hope In Cancer Battle: FDA Grants Breakthrough Device Status To Vivos Inc.'s RadioGel - Vimarsana News

New Hope In Cancer Battle: FDA Grants Breakthrough Device Status To Vivos Inc.'s RadioGel

In a significant advancement for cancer therapy, the Food and Drug Administration (FDA) has awarded RadioGel Precision Radionuclide Therapy the coveted…

Source: biztoc.com
Radiogel™ Precision Radionuclide Therapy™ Receives FDA Breakthrough Device Designation - Vimarsana News

Radiogel™ Precision Radionuclide Therapy™ Receives FDA Breakthrough Device Designation

Richland WA, Dec. 20, 2023 -- Vivos Inc. , Vivos Inc is pleased to announce that the Food and Drug Administration has granted RadioGel Precision Radionuclide Therapy the designation as a...

Envoy Medical to Host Fireside Chat Event December 7 - Vimarsana News

Envoy Medical to Host Fireside Chat Event December 7

Analyst Hosted Event to Feature Comprehensive Discussion of Envoy Medical’s Products, Interviews with Two Study Investigators and Key Opinion Leaders in Cochlear Implants WHITE BEAR LAKE,...

Aethlon Medical (NASDAQ: AEMD) Research/Media Alert: "Expect Focus on Oncology Studies; Cost Containment Efforts" - Vimarsana News

Aethlon Medical (NASDAQ: AEMD) Research/Media Alert: "Expect Focus on Oncology Studies; Cost Containment Efforts"

Aethlon Medical (NASDAQ: AEMD) Research/Media Alert: Expect Focus on Oncology Studies; Cost Containment Efforts